CureVac N.V. revenue breakdown overview

CureVac N.V. revenue for the last year amounted to 554.04 M USD, the most of which — 578.90 M USD — came from its highest performing source at the moment, Transformative Medicines, the year earlier bringing 58.12 M USD. The greatest contribution to the revenue figure was made by Belgium — last year it brought CureVac N.V. 562.32 M USD, and the year before that — 50.95 M USD.